Buy, Sell or Hold: Oncolytics Biotech (ONC-T) — Stock Predictions at Stockchase

skip to content

Home Daily Stock Opinions and Ratings Oncolytics Biotech (ONC-T)

TSE:ONC

1.22

0.01 (0.81%) 1d

Related posts

Weekly 52-Week Low (or 52-Week High): BAM-T, IAG-T, ONC-T, CCB-X and More 52-Week Highs and Lows (Oct 02-08)Most Anticipated Earnings: BLDP-T, BOS-T and more Canadian Companies Reporting Earnings this Week (May 06-10)Top Biotech and Pharma Stocks to Bet on Cancer Cure & Control

DON'T BUY

The technicals do not look good at all – with a decline lasting over the past two months. He would not touch this one at all. A 50 day moving average would be a buy signal if it can trade back above it.

biotechnology / pharmaceutical

COMMENT

Phase 2 cancer company with some pretty decent results. They are a long way away from where they want to be. Product has huge potential.

biotechnology / pharmaceutical

WEAK BUY

Not aware of any upcoming short term catalysts. Continuing with their trials. Never had bad results. Very volatile and still early stage.

biotechnology / pharmaceutical

WAIT

Has a pretty high beta, so the stock goes up and down like a yo-yo. Likes with the company is doing. At some point, a major pharmaceutical company will get interested in their technology. Would like to see more trials and results.

biotechnology / pharmaceutical

DON'T BUY

If they can find the right deals and get through the clinical trials, the upside would be phenomenal. Very volatile right now.

biotechnology / pharmaceutical

WEAK BUY

A wild stock. Created a virus that could reduce cancer dramatically. Long term potential could be good. Trials have only been small ones. Risky.

biotechnology / pharmaceutical

WEAK BUY

Biotechs have had good moves. Has a ways to go before their drug is on the market. Speculative in the short term.

biotechnology / pharmaceutical

WEAK BUY

Interesting technology. Trials are turning out well, but too small a sampling at this time. Speculative.

biotechnology / pharmaceutical

Showing 1 to 8 of 8 entries

«
‹
1
›
»

Oncolytics Biotech(ONC-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Oncolytics Biotech is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Oncolytics Biotech(ONC-T) Frequently Asked Questions

What is Oncolytics Biotech stock symbol?

Oncolytics Biotech is a Canadian stock, trading under the symbol ONC-T on the Toronto Stock Exchange (ONC-CT). It is usually referred to as TSX:ONC or ONC-T

Is Oncolytics Biotech a buy or a sell?

In the last year, there was no coverage of Oncolytics Biotech published on Stockchase.

Is Oncolytics Biotech a good investment or a top pick?

Oncolytics Biotech was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Oncolytics Biotech.

Why is Oncolytics Biotech stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Oncolytics Biotech worth watching?

0 stock analysts on Stockchase covered Oncolytics Biotech In the last year. It is a trending stock that is worth watching.

What is Oncolytics Biotech stock price?

On 2024-12-11, Oncolytics Biotech (ONC-T) stock closed at a price of $1.22.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

© Stockchase Inc.